Journal
DIABETES
Volume 65, Issue 2, Pages 463-475Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db15-1168
Keywords
-
Categories
Funding
- INSERM
- CNRS
- University of Montpellier
- National Biophotonics and Imaging Platform of Ireland (NBIPI)
- IBiSA
- Diabetes UK [12/0004431]
- Medical Research Council [MR/N00275X/1]
- European Foundation for the Study of Diabetes (EFSD/Novo Nordisk Rising Star Fellowship)
- Agence Nationale de la Recherche (ANR)
- Region Languedoc-Roussillon (IPAM)
- [BETA-DYN JCJC13]
- Medical Research Council [MR/N00275X/1] Funding Source: researchfish
- MRC [MC_U117570590, MR/N00275X/1] Funding Source: UKRI
Ask authors/readers for more resources
Pancreatic beta-cells modulate insulin secretion through rapid sensing of blood glucose and integration of gut derived signals. Increased insulin demand during pregnancy and obesity alters islet function and mass and leads to gestational diabetes mellitus and type 2 diabetes in predisposed individuals. However, it is unclear how blood-borne factors dynamically access the islets of Langerhans. Thus, understanding the changes in circulating molecule distribution that accompany compensatory beta-cell expansion may be key to developing novel antidiabetic therapies. Here, using two-photon microscopy in vivo in mice, we demonstrate that islets are almost instantly exposed to peaks of circulating molecules, which rapidly pervade the tissue before clearance. In addition, both gestation and short-term high-fat-diet feeding decrease molecule extravasation and uptake rates in vivo in islets, independently of beta-cell expansion or islet blood flow velocity. Together, these data support a role for islet vascular permeability in shaping beta-cell adaptive responses to metabolic demand by modulating the access and sensing of circulating molecules.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available